Iterum Therapeutics plc (ITRMF) Non-Current Assets (2017 - 2025)

Iterum Therapeutics' Non-Current Assets history runs 9 years deep, the most recent figure standing at $18.8 million for Q3 2025.

• In Q3 2025, Non-Current Assets rose 26722.86% year-over-year to $18.8 million; the TTM figure through Sep 2025 stood at $77.2 million (up 4228.1% YoY), while the FY2024 annual figure was $19.8 million, up 2887.63% from the prior year.
• Non-Current Assets for Q3 2025 stood at $18.8 million, down from $19.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $19.8 million in Q4 2024, with the low at $70000.0 in Q3 2024.
• The 5-year median for Non-Current Assets is $5.8 million (2022), against an average of $7.7 million.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 94.17% in 2024, then jumped 26722.86% in 2025.
• Iterum Therapeutics' Non-Current Assets stood at $8.2 million in 2021, then slumped by 46.75% to $4.4 million in 2022, then tumbled by 84.89% to $663000.0 in 2023, then soared by 2887.63% to $19.8 million in 2024, then dropped by 5.21% to $18.8 million in 2025.
• Business Quant data shows ITRMF's Non-Current Assets at $18.8 million in Q3 2025, $19.1 million in Q2 2025, and $19.5 million in Q1 2025.